179 related articles for article (PubMed ID: 22207709)
1. High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature.
Bloch M; Prock A; Paonessa F; Benz V; Bähr IN; Herbst L; Witt H; Kappert K; Spranger J; Stawowy P; Unger T; Fusco A; Sedding D; Brunetti A; Foryst-Ludwig A; Kintscher U
Circ Res; 2012 Feb; 110(3):394-405. PubMed ID: 22207709
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
[TBL] [Abstract][Full Text] [Related]
4. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
5. Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension.
Chang L; Villacorta L; Zhang J; Garcia-Barrio MT; Yang K; Hamblin M; Whitesall SE; D'Alecy LG; Chen YE
Circulation; 2009 Apr; 119(16):2161-9. PubMed ID: 19364979
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
7. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
[TBL] [Abstract][Full Text] [Related]
8. Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Hasan DM; Starke RM; Gu H; Wilson K; Chu Y; Chalouhi N; Heistad DD; Faraci FM; Sigmund CD
Hypertension; 2015 Jul; 66(1):211-20. PubMed ID: 25916724
[TBL] [Abstract][Full Text] [Related]
9. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
11. Effect of a peroxisome proliferator-activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in rats.
Lim S; Ahn BY; Chung SS; Park HS; Cho BJ; Kim M; Choi SH; Lee IK; Lee SW; Choi SJ; Chung CH; Cho YM; Lee HK; Park KS
Atherosclerosis; 2009 Oct; 206(2):411-7. PubMed ID: 19339015
[TBL] [Abstract][Full Text] [Related]
12. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.
Pascual G; Fong AL; Ogawa S; Gamliel A; Li AC; Perissi V; Rose DW; Willson TM; Rosenfeld MG; Glass CK
Nature; 2005 Sep; 437(7059):759-63. PubMed ID: 16127449
[TBL] [Abstract][Full Text] [Related]
13. Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity.
Tyagi N; Moshal KS; Sen U; Lominadze D; Ovechkin AV; Tyagi SC
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):21-7. PubMed ID: 17543202
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
Ohshima T; Koga H; Shimotohno K
J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
[TBL] [Abstract][Full Text] [Related]
15. Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor.
Li Y; Lu J; Prochownik EV
J Biol Chem; 2007 May; 282(18):13363-71. PubMed ID: 17350957
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
18. Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ mediates pioglitazone-reduced vascular lesion formation.
Hamblin M; Chang L; Zhang H; Yang K; Zhang J; Chen YE
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):352-9. PubMed ID: 21088248
[TBL] [Abstract][Full Text] [Related]
19. PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells.
Huang CD; Hsiung TC; Ho SC; Lee KY; Chan YF; Kuo LW; Lin SM; Wang CH; Lin HC; Kuo HP
Biomed J; 2014; 37(4):191-8. PubMed ID: 25116714
[TBL] [Abstract][Full Text] [Related]
20. A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription.
Krätzner R; Fröhlich F; Lepler K; Schröder M; Röher K; Dickel C; Tzvetkov MV; Quentin T; Oetjen E; Knepel W
Mol Pharmacol; 2008 Feb; 73(2):509-17. PubMed ID: 17962386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
